MX343269B - Procesos de cultivo celular. - Google Patents
Procesos de cultivo celular.Info
- Publication number
- MX343269B MX343269B MX2015014311A MX2015014311A MX343269B MX 343269 B MX343269 B MX 343269B MX 2015014311 A MX2015014311 A MX 2015014311A MX 2015014311 A MX2015014311 A MX 2015014311A MX 343269 B MX343269 B MX 343269B
- Authority
- MX
- Mexico
- Prior art keywords
- cell culture
- culture processes
- urin
- adamts
- cho
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6454—Dibasic site splicing serine proteases, e.g. kexin (3.4.21.61); furin (3.4.21.75) and other proprotein convertases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21075—Furin (3.4.21.75)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24087—ADAMTS13 endopeptidase (3.4.24.87)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere a cultivo de células de mamífero que secretan proteína heteróloga, tal como células CHO ó BHK células, a una temperatura de 35.1°C a 36.50°C y/o en un pH de 7.15 a 7.20 y/o en una concentración de CO2 disuelto al 10% o menor. Las proteínas heterólogas preferidas son el Factor VIII, ADAMTS-13, furina o el Factor VIl.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US932807P | 2007-12-27 | 2007-12-27 | |
PCT/US2008/088036 WO2009086309A2 (en) | 2007-12-27 | 2008-12-22 | Cell culture processes |
Publications (1)
Publication Number | Publication Date |
---|---|
MX343269B true MX343269B (es) | 2016-10-31 |
Family
ID=40350258
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014003366A MX343271B (es) | 2007-12-27 | 2008-12-22 | Procesos de cultivo celular. |
MX2015014311A MX343269B (es) | 2007-12-27 | 2008-12-22 | Procesos de cultivo celular. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014003366A MX343271B (es) | 2007-12-27 | 2008-12-22 | Procesos de cultivo celular. |
Country Status (21)
Country | Link |
---|---|
US (2) | US9359629B2 (es) |
EP (4) | EP3255152A1 (es) |
JP (3) | JP5727790B2 (es) |
KR (4) | KR101659458B1 (es) |
CN (2) | CN101910408A (es) |
AR (2) | AR069956A1 (es) |
AU (1) | AU2008345231B2 (es) |
BR (1) | BR122019022434B8 (es) |
CA (1) | CA2709890A1 (es) |
DK (3) | DK2574676T3 (es) |
ES (3) | ES2649094T3 (es) |
HK (1) | HK1246827A1 (es) |
HR (3) | HRP20171375T1 (es) |
HU (2) | HUE036712T2 (es) |
MX (2) | MX343271B (es) |
NZ (1) | NZ586250A (es) |
PL (3) | PL2574676T3 (es) |
PT (3) | PT2235197T (es) |
SG (2) | SG187397A1 (es) |
SI (3) | SI2574677T1 (es) |
WO (1) | WO2009086309A2 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0716762A2 (pt) | 2006-09-13 | 2013-09-24 | Abbott Lab | melhorias da cultura celular |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
EP2921501A1 (en) | 2008-10-20 | 2015-09-23 | Abbvie Inc. | Isolation and purification of antibodies using Protein A affinity chromatography |
CA2738499A1 (en) | 2008-10-20 | 2010-04-29 | Abbott Laboratories | Viral inactivation during purification of antibodies |
US8580554B2 (en) | 2009-07-31 | 2013-11-12 | Baxter International Inc. | Method of producing a polypeptide or virus of interest in a continuous cell culture |
BR122021005965B1 (pt) | 2009-07-31 | 2022-01-25 | Baxalta Incorporated | Método para produzir uma composição de desintegrina e metaloproteinase com motivo trombospondina (adamts) |
JP5953502B2 (ja) * | 2010-07-08 | 2016-07-20 | バクスアルタ ゲーエムベーハー | 細胞培養による組換え型高分子量vWF産生方法 |
WO2012122611A1 (en) * | 2011-03-11 | 2012-09-20 | Universidade De São Paulo - Usp | Method for the production of recombinant human factor viii |
EP2511293A1 (en) | 2011-04-13 | 2012-10-17 | LEK Pharmaceuticals d.d. | A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins |
EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
US9334319B2 (en) | 2012-04-20 | 2016-05-10 | Abbvie Inc. | Low acidic species compositions |
US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
US9249182B2 (en) | 2012-05-24 | 2016-02-02 | Abbvie, Inc. | Purification of antibodies using hydrophobic interaction chromatography |
KR20150043523A (ko) | 2012-09-02 | 2015-04-22 | 애브비 인코포레이티드 | 단백질 불균일성의 제어 방법 |
US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
SG11201507230PA (en) | 2013-03-12 | 2015-10-29 | Abbvie Inc | Human antibodies that bind human tnf-alpha and methods of preparing the same |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
US8921526B2 (en) | 2013-03-14 | 2014-12-30 | Abbvie, Inc. | Mutated anti-TNFα antibodies and methods of their use |
US9499614B2 (en) | 2013-03-14 | 2016-11-22 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides |
KR20150026024A (ko) * | 2013-08-30 | 2015-03-11 | 한미약품 주식회사 | 인간 혈액응고 7인자 유도체의 대량 생산 방법 |
US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
US8946395B1 (en) | 2013-10-18 | 2015-02-03 | Abbvie Inc. | Purification of proteins using hydrophobic interaction chromatography |
US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
CA2943357C (en) * | 2014-03-25 | 2023-06-27 | Genentech, Inc. | Methods of preparing a poloxamer for use in cell culture medium |
WO2015157335A1 (en) * | 2014-04-10 | 2015-10-15 | Bayer Healthcare Llc | Compounded media powder formulation and method of preparation of liquid medium for cell culture |
RU2016152693A (ru) * | 2014-06-03 | 2018-07-09 | Люпин Лимитед | Способ культивирования клеток для получения белка |
ES2709994T3 (es) | 2014-06-04 | 2019-04-22 | Amgen Inc | Métodos de recolección en cultivos de células de mamífero |
EP3298036B1 (en) | 2015-05-22 | 2022-04-06 | CSL Behring Lengnau AG | Methods for preparing modified von willebrand factor |
JP7213180B2 (ja) * | 2016-10-19 | 2023-01-26 | エフ.ホフマン-ラ ロシュ アーゲー | 免疫コンジュゲートを製造するための方法 |
CN114657118B (zh) * | 2021-12-31 | 2023-12-01 | 广州齐志生物工程设备有限公司 | 一种2bs细胞在生物反应器内的多倍放大方法 |
Family Cites Families (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4456591A (en) * | 1981-06-25 | 1984-06-26 | Baxter Travenol Laboratories, Inc. | Therapeutic method for activating factor VII |
SE8501050D0 (sv) | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
US4868112A (en) | 1985-04-12 | 1989-09-19 | Genetics Institute, Inc. | Novel procoagulant proteins |
GR860984B (en) * | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
US5250421A (en) | 1986-01-03 | 1993-10-05 | Genetics Institute, Inc. | Method for producing factor VIII:C-type proteins |
US5422260A (en) | 1986-05-29 | 1995-06-06 | Genetics Institute, Inc. -Legal Affairs | Human factor VIII:c muteins |
US5171844A (en) | 1987-06-12 | 1992-12-15 | Gist-Brocades N.W. | Proteins with factor viii activity: process for their preparation using genetically-engineered cells and pharmaceutical compositions containing them |
US5200510A (en) * | 1987-06-16 | 1993-04-06 | Zymogenetics, Inc. | Method for purifying factor viii:c, von willebrand factor and complexes thereof |
US4921792A (en) * | 1987-11-27 | 1990-05-01 | Miles Inc. | Continuous cell dispersion, cultivation and substance recovery process |
JPH0787799B2 (ja) * | 1988-03-30 | 1995-09-27 | 森永製菓株式会社 | モノクローナル抗体生産増強法 |
US6100050A (en) | 1989-08-17 | 2000-08-08 | Dade Behring Ag | Factor VIII:Ca chromogenic assay |
NL9000917A (nl) | 1989-10-25 | 1991-05-16 | Holland Biotechnology | Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten. |
US5580560A (en) | 1989-11-13 | 1996-12-03 | Novo Nordisk A/S | Modified factor VII/VIIa |
SE465222C5 (sv) | 1989-12-15 | 1998-02-10 | Pharmacia & Upjohn Ab | Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning |
AT393356B (de) * | 1989-12-22 | 1991-10-10 | Immuno Ag | Verfahren zur herstellung von fsme-virus-antigen |
GB9022545D0 (en) * | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
ATE158816T1 (de) | 1990-11-26 | 1997-10-15 | Genetics Inst | Expression von pace in wirtszellen und verfahren zu dessen verwendung |
US5997864A (en) | 1995-06-07 | 1999-12-07 | Novo Nordisk A/S | Modified factor VII |
JP3459416B2 (ja) | 1991-02-28 | 2003-10-20 | ザイモジェネティクス,インコーポレイティド | 修飾されたファクター▲vii▼ |
US5661008A (en) | 1991-03-15 | 1997-08-26 | Kabi Pharmacia Ab | Recombinant human factor VIII derivatives |
DK0627924T3 (da) | 1992-10-02 | 2001-04-30 | Genetics Inst | Sammensætning, der omfatter koagulationsfaktor VIII formulering, fremgangsmåde til dens fremstilling og anvendelse af et overfladeaktivt middel som stabilisator |
AT403167B (de) * | 1994-11-14 | 1997-11-25 | Immuno Ag | Selektion und expression von fremdproteinen mittels eines selektions-amplifikations-systems |
EP0871753A2 (en) * | 1995-12-15 | 1998-10-21 | Systemix, Inc. | Method for obtaining retroviral vector supernatant having high transduction efficiency |
AT403765B (de) | 1996-04-12 | 1998-05-25 | Immuno Ag | Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex |
WO1998000521A1 (fr) * | 1996-06-28 | 1998-01-08 | The Green Cross Corporation | Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives |
US5854021A (en) | 1997-02-28 | 1998-12-29 | Bayer Corporation | Enhance protein production method |
US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
US6475725B1 (en) | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
AT407255B (de) | 1997-06-20 | 2001-02-26 | Immuno Ag | Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons |
US6017882A (en) | 1997-10-23 | 2000-01-25 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6358703B1 (en) | 1998-12-10 | 2002-03-19 | Bayer Corporation | Expression system for factor VIII |
BR0008405B1 (pt) | 1999-02-22 | 2014-04-22 | Baxter Int | Composição de fator viii formulada sem a adição de albumina, uso de uma composição de fator viii, e, método de liofilizar uma formulação farmacêutica aquosa |
WO2001003726A1 (en) | 1999-07-13 | 2001-01-18 | Biovitrum Ab | Stable factor viii compositions |
JP4451514B2 (ja) | 1999-08-24 | 2010-04-14 | 財団法人化学及血清療法研究所 | 血液凝固第vii因子改変体 |
JP2001120262A (ja) * | 1999-10-26 | 2001-05-08 | Welfide Corp | 生理活性物質の産生増強方法 |
SE518174C2 (sv) * | 1999-11-16 | 2002-09-03 | Appliedsensor Sweden Ab | Detektionsförfarande av oönskad mikrobiell infektion i animaliecellodling |
RU2278123C2 (ru) | 2000-02-11 | 2006-06-20 | Максиджен Холдингз Лтд. | Молекулы, подобные фактору vii или viia |
US6168941B1 (en) * | 2000-04-07 | 2001-01-02 | Genvec, Inc. | Method of producing adenoviral vector stocks |
AU2001254624A1 (en) | 2000-05-03 | 2001-11-12 | Novo-Nordisk A/S | Human coagulation factor vii variants |
EP1319067A2 (en) | 2000-09-13 | 2003-06-18 | Novo Nordisk A/S | Human coagulation factor vii variants |
US20040185535A1 (en) * | 2003-03-21 | 2004-09-23 | Giles Wilson | Industrial-scale serum-free production of recombinant FVII in mammalian cells |
US7173000B2 (en) | 2000-11-09 | 2007-02-06 | The Scripps Research Institute | Modified factor VIIa |
US6926894B2 (en) | 2000-11-22 | 2005-08-09 | Baxter Aktiengesellschaft | Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
US20030040095A1 (en) * | 2001-03-16 | 2003-02-27 | Achille Arini | Method for the production of pharmaceutically active recombinant proteins |
AU2002249096B2 (en) | 2001-03-22 | 2007-06-28 | Novo Nordisk Health Care Ag | Coagulation factor VII derivatives |
JP2003047461A (ja) * | 2001-07-31 | 2003-02-18 | Astec:Kk | アパタイトシ−トを用いた細胞の高密度細胞培養法及び培養装置、細胞培養モジュール |
WO2003020919A2 (en) * | 2001-08-31 | 2003-03-13 | Bayer Healthcare Ag | A unit and a process for carrying out high cell density fermentation |
CA2461003A1 (en) | 2001-09-27 | 2003-04-03 | Novo Nordisk Health Care Ag | Human coagulation factor vii polypeptides |
HUP0402158A2 (hu) * | 2001-10-02 | 2005-01-28 | Novo Nordisk Health Care Ag | Rekombináns fehérjék előállítási eljárása eukarióta sejtekben |
JP2005512524A (ja) | 2001-11-02 | 2005-05-12 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | ヒト凝固第vii因子ポリペプチド |
US20030119723A1 (en) | 2001-11-09 | 2003-06-26 | Rasmus Rojkjaer | Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides |
PL214284B1 (pl) * | 2002-07-09 | 2013-07-31 | Baxter Healthcare Sa | Sposób wytwarzania wirusa oraz sposób wytwarzania immunogennej kompozycji zawierajacej wirusa albo antygen wirusa |
JP4651536B2 (ja) * | 2003-04-17 | 2011-03-16 | 田辺三菱製薬株式会社 | 組換えアンチトロンビンの製造方法 |
JP2007525984A (ja) * | 2004-03-05 | 2007-09-13 | ディーエスエム アイピー アセッツ ビー.ブイ. | 連続的灌流および交互接線流による細胞培養の方法 |
EP1851305B1 (en) * | 2005-02-11 | 2012-01-18 | Novo Nordisk Health Care AG | Production of a polypeptide in a serum-free cell culture liquid containing plant protein hydrolysate |
PL2522717T3 (pl) * | 2006-01-04 | 2014-08-29 | Baxalta Inc | Pożywki do hodowli komórkowych wolne od oligopeptydów |
WO2008141824A2 (en) | 2007-05-22 | 2008-11-27 | Baxter International Inc. | Preparative purification process for human furin |
-
2008
- 2008-12-22 EP EP17175185.2A patent/EP3255152A1/en not_active Withdrawn
- 2008-12-22 EP EP12198392.8A patent/EP2574676B1/en active Active
- 2008-12-22 ES ES12198754.9T patent/ES2649094T3/es active Active
- 2008-12-22 KR KR1020107016654A patent/KR101659458B1/ko active IP Right Grant
- 2008-12-22 CA CA2709890A patent/CA2709890A1/en not_active Abandoned
- 2008-12-22 BR BR122019022434A patent/BR122019022434B8/pt active IP Right Grant
- 2008-12-22 SI SI200831871T patent/SI2574677T1/sl unknown
- 2008-12-22 SG SG2012095329A patent/SG187397A1/en unknown
- 2008-12-22 CN CN2008801232545A patent/CN101910408A/zh active Pending
- 2008-12-22 SI SI200831864T patent/SI2574676T1/sl unknown
- 2008-12-22 MX MX2014003366A patent/MX343271B/es unknown
- 2008-12-22 ES ES12198392.8T patent/ES2647294T3/es active Active
- 2008-12-22 US US12/341,807 patent/US9359629B2/en active Active
- 2008-12-22 EP EP08868009.5A patent/EP2235197B1/en active Active
- 2008-12-22 ES ES08868009.5T patent/ES2644089T3/es active Active
- 2008-12-22 DK DK12198392.8T patent/DK2574676T3/en active
- 2008-12-22 WO PCT/US2008/088036 patent/WO2009086309A2/en active Application Filing
- 2008-12-22 AU AU2008345231A patent/AU2008345231B2/en active Active
- 2008-12-22 PL PL12198392T patent/PL2574676T3/pl unknown
- 2008-12-22 CN CN201610625651.9A patent/CN106222220A/zh active Pending
- 2008-12-22 DK DK12198754.9T patent/DK2574677T3/da active
- 2008-12-22 PT PT88680095T patent/PT2235197T/pt unknown
- 2008-12-22 KR KR1020187000372A patent/KR20180005287A/ko not_active Application Discontinuation
- 2008-12-22 EP EP12198754.9A patent/EP2574677B1/en active Active
- 2008-12-22 KR KR1020167025638A patent/KR101798813B1/ko active IP Right Grant
- 2008-12-22 PL PL12198754T patent/PL2574677T3/pl unknown
- 2008-12-22 MX MX2015014311A patent/MX343269B/es unknown
- 2008-12-22 SI SI200831865T patent/SI2235197T1/sl unknown
- 2008-12-22 PT PT121983928T patent/PT2574676T/pt unknown
- 2008-12-22 PL PL08868009T patent/PL2235197T3/pl unknown
- 2008-12-22 KR KR1020177032356A patent/KR101818411B1/ko active IP Right Grant
- 2008-12-22 HU HUE08868009A patent/HUE036712T2/hu unknown
- 2008-12-22 NZ NZ586250A patent/NZ586250A/xx unknown
- 2008-12-22 DK DK08868009.5T patent/DK2235197T3/en active
- 2008-12-22 JP JP2010540844A patent/JP5727790B2/ja active Active
- 2008-12-22 PT PT121987549T patent/PT2574677T/pt unknown
- 2008-12-22 HU HUE12198392A patent/HUE036496T2/hu unknown
- 2008-12-22 SG SG10201503304RA patent/SG10201503304RA/en unknown
- 2008-12-23 AR ARP080105692A patent/AR069956A1/es active IP Right Grant
-
2014
- 2014-03-10 JP JP2014045879A patent/JP5890854B2/ja active Active
-
2015
- 2015-10-22 JP JP2015207654A patent/JP2016013140A/ja not_active Withdrawn
-
2016
- 2016-05-03 US US15/145,618 patent/US20160244506A1/en not_active Abandoned
-
2017
- 2017-09-14 HR HRP20171375TT patent/HRP20171375T1/hr unknown
- 2017-09-14 HR HRP20171374TT patent/HRP20171374T1/hr unknown
- 2017-10-05 HR HRP20171495TT patent/HRP20171495T1/hr unknown
-
2018
- 2018-01-29 AR ARP180100205A patent/AR110864A2/es unknown
- 2018-05-09 HK HK18105999.0A patent/HK1246827A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX343271B (es) | Procesos de cultivo celular. | |
AU2019268194A1 (en) | Cell culture system | |
DE602005002829D1 (de) | Verwendung eines serumfreien zellkulturmediums zur produktion von il-18bp in säugerzellen | |
TW200636068A (en) | A method of culturing a cell and use of the same | |
UA92157C2 (ru) | Способ продуцирования гормона роста | |
MX2009010154A (es) | Materiales y metodos para la produccion eficiente de succinato y malato. | |
CL2011001926A1 (es) | Biorreactor para el cultivo de celulas de mamiferos donde dicho biorreactor posee un volumen de al menos 4000 l y al menos un impulsor superior y al menos un impulsor de fondo, donde el impulsor superior es un impulsor de hidroplano; metodo de cultivo; sistema de bioreactor. | |
MY156588A (en) | Systems using cell culture for production of isoprene | |
MX2009011805A (es) | Mejora de las concentraciones de polipeptido del factor viii en cultivos celulares. | |
MX2007002380A (es) | Produccion de polipeptidos. | |
CL2008001156A1 (es) | Metodo para producir una proteina de fusion tnfr en un cultivo celular que comprende cultivar celulas de mamifero que contienen un gen que codifica la proteina de fusion en un medio de cultivo de celulas que comprende un compuesto anti-envejecimiento. | |
WO2008135498A3 (en) | Prevention of protein degradation in mammalian cell cultures | |
DK1623023T3 (da) | Kulturer af E1-immortaliserede celler og fremgangsmåder til dyrkning deraf til forögelse af produktudbytter derfra | |
MX2010002426A (es) | Agente para promover la adhesion de las celulas del endotelio corneal. | |
ATE452664T1 (de) | Verfahren und vorrichtung zum züchten von zellen | |
GB0702261D0 (en) | No title | |
MX2008013809A (es) | Celulas madre adultas derivadas de adiposa en regeneracion hepatica. | |
ATE336567T1 (de) | Zellkulturmedium | |
NZ595833A (en) | Method of producing a lipolytic enzyme | |
PT2401383E (pt) | Métodos para seleccionar células eucarióticas que expressam uma proteína heteróloga | |
NZ599479A (en) | Improved reverse genetics methods for virus rescue | |
WO2009061905A8 (en) | Methods of measuring cell viability without using control cells | |
GB2450599A (en) | Automated culture of stem cells | |
MX2010001996A (es) | Vehiculo para celulas que contienen colageno. | |
WO2010115634A8 (en) | Method for improved single cell cloning |